Lyell immunopharma market cap

Author: uzrd

August undefined, 2024

WebWith Lyell Immunopharma stock trading at $2.79 per share, the total value of Lyell Immunopharma stock (market capitalization) is $696.41M. Lyell Immunopharma … Web6 apr. 2024 · About LYEL. Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic …

Lyell Immunopharma, Inc. (LYEL) Stock Price - coincodex.com

WebGet the latest Lyell Immunopharma Inc (LYEL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebAcum 23 ore · Amit Sinha, Head of Life Sciences Investing within Goldman Sachs Asset Management and Lynn Seely, M.D., President and CEO of Lyell Immunopharma to join TORL Board of Managers as part of Series B ... halestorm influences

LYEL - Lyell Immunopharma, Inc. Stock Price and Quote

WebTen years of experience in Program Management, Product Management, and Business Analysis. Lead initiatives/programs from inception to production in various domains such as Healthcare, Operations ... WebCurrent and historical revenue charts for Lyell Immunopharma. As of April 2024 Lyell Immunopharma's TTM revenue is of $39.11 M. companies: 7,323 total market cap: … Web28 ian. 2024 · Research Lyell Immunopharma, Inc. (LYEL) stock with daily updated analysis. Home Markets Discover Watchlist Portfolios Screener. Stocks / United States / ... How do Lyell Immunopharma's earnings and revenue compare to its market cap? LYEL fundamental statistics; Market Cap: US$832.75m: Earnings (TTM)-US$258.43m: … bumble bees pics

LYEL Stock Price Forecast. Should You Buy LYEL? - StockInvest.us

Lyell immunopharma market cap

Lyell Immunopharma : Termination of Material Agreement

WebLyell Immunopharma market cap as of April 07, 2024 is $0.64B . Lyell Immunopharma market cap history and chart from 2024 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding WebProvide the latest Lyell Immunopharma(LYEL) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company introduction, dividends and dividend information, you can also use Moomoo to open an account to trade Lyell Immunopharma stocks，we will provide investors with reference decision data.

Did you know?

Web6 apr. 2024 · The Lyell Immunopharma, Inc. stock price gained 8.56% on the last trading day (Thursday, 6th Apr 2024), rising from $2.57 to $2.79. During the last trading day the stock fluctuated 11.55% from a day low at $2.51 to a day high of $2.80. The price has risen in 7 of the last 10 days and is up by 37.44% over the past 2 weeks. WebStock analysis for Lyell Immunopharma Inc (LYEL:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Web🚀 Lyell Immunopharma stock price forecast: $12; Market Cap: 1.62B, Enterprise value: 1.47B, P/E: 3.93, PEG ratio: -0.19, EPS: -0.98, Revenue: 41.87M, EBITDA: -218 ... WebAs of April 2024 Lyell Immunopharma's TTM earnings per share are -$0.91. companies: 7,324 total market cap: $87.252 T. Global ranking; Ranking by countries. America ...

Web12 apr. 2024 · Lyell Immunopharma Inc. (NASDAQ: LYEL) stock closed at 2.81 per share at the end of the most recent trading day (a 5.24 % change compared to the prior day closing price) with a volume of 873.77K shares and market capitalization of 691.42M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in … Web28 mar. 2024 · Detailed statistics for Lyell Immunopharma, Inc. (LYEL) stock, including valuation metrics, financial numbers, share information and more. ... LYEL has a market cap or net worth of $562.87 million. The enterprise value is -$30.62 million. Market Cap: 562.87M: Enterprise Value -30.62M: Important Dates.

WebBuy Lyell Immunopharma, Inc Shares from India at $2.61 (0 Commission) today. Start investing in Lyell Immunopharma, Inc stocks from India now with fractional investing only on INDmoneyapp

Web11 apr. 2024 · Lyell Immunopharma Inc., whose market valuation is $613.91 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.26 per share this quarter, however they have predicted annual earnings per share of ... halestorm interviewsWeb13 apr. 2024 · The company has a market cap of $765.03 million, a PE ratio of 61.35 and a beta of 0.30. ... Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $2.67; Mondee (NASDAQ:MOND) Shares Gap Down to $12. ... halestorm innocence meaningWebEvaluate Lyell Immunopharma's potential for growth with their P/E ratio. Gain insight into market expectations and make informed investment decisions. Companies: 12513 Total Market Cap: $83.1T. Login. Rank by Country. America. United States (5421) Canada (682) Brazil (292) Bermuda (53) Cayman Islands (39) Europe. United Kingdom (1087) halestorm innocence